Given the crucial role of the NFkB pathway in the pathophysiology of HL and its involvement in the survival mechanisms of HRS cells, considering the therapeutic and pharmacological targeting of this pathway seems appropriate. Here, NFKB1 is linked to Hodgkins lymphoma.